Investor insights
Sectors invested in
Funding rounds participated in
$25M sweet spot round size
Most of their 116 investments are in rounds between $10M and $45M
Investor type
Basic info
Industry
Sectors
Date founded
1997
Investments made
Bridge Medicines LLC raised $10M on November 13, 2020
Investors: Bay City Capital
SemBioSys Genetics Inc raised undisclosed on October 1, 2020
Investors: Bay City Capital
Xilio Therapeutics, Inc. raised $101M on March 2, 2020
Investors: RiverVest Venture Partners, SV Life Sciences, Takeda UK Limited, M Ventures, Solasta Ventures, Atlas Venture, F-Prime Capital Partners and Bay City Capital
Imara Inc. raised $63M on March 18, 2019
Investors: Lundbeckfonden / Lundbeck Foundation, OrbiMed Advisors, RA Capital Management, L.P., Arix Bioscience plc and Bay City Capital
Gossamer Bio raised $230M on July 23, 2018
Investors: Hillhouse Capital Management, Abu Dhabi Investment Authority (ADIA), ARCH Venture Partners, Polaris Partners, The Invus Group, Omega Funds, The Baupost Group and Bay City Capital
KBP Biosciences raised $76M on January 5, 2018
Investors: Korea Investment Partners, Sangel Capital, Cowin Venture Capital, Efung Capital, PingAn Ventures and Bay City Capital
Oculis S.A. raised $21M on January 4, 2018
Investors: - and Bay City Capital
Gritstone bio raised undisclosed on October 1, 2017
Investors: Bay City Capital
Kezar Life Sciences raised $50M on July 25, 2017
Investors: Chiesi Ventures, Omega Funds, AJU IB INVESTMENT, Qiming Venture Partners, Pappas Ventures, Cowen Inc. and Bay City Capital
VYNE Therapeutics raised $51M on July 18, 2017
Investors: Aisling Capital, venBio Partners, F-Prime Capital Partners, Vivo Capital, Novo Holdings, Presidio Partners and Bay City Capital